Monday, September 27, 2021
FDA, CDC Approve Pfizer-BioNTech Booster for All Adults 65 & Older
Additional guidance is also expected in the near future for individuals who received the two-dose vaccine from Moderna, or the single-shot vaccine produced by Johnson & Johnson, with those manufacturers currently submitting data to the FDA and public health authorities for consideration.
On Friday, (Sept. 24), Centers for Disease Control & Prevention Director Dr. Rochelle Walensky endorsed a third, COVID-19 booster dose for adults ages 65 and older who received the Pfizer-BioNTech vaccine at least six (6) months prior. This endorsement followed the emergency use authorization issued last week by the U.S. Food and Drug Administration (FDA), with guidance from both public health agencies pertaining to all individuals 65 and older, and those ages 18-65 who are at heightened risk of COVID-19 exposure at work (including hospital, health care and long-term care workers, teachers, etc.).
The recommended booster dose is aimed at counteracting “waning immunity” from the two, initial vaccine doses and maximizing protection against the virus for the most at-risk population segments.
Within the Discovery Senior Living family of communities, regional operation leaders are currently working with communities and established vaccine partners to arrange booster clinics, if being offered in the local area.
We will update this page with further updates and new developments as they become available.